NewsBenzingaReported Saturday, Climb Bio Reports Initial PrisMN Phase 2 Data Showing 200 mg Budoprutug Delivered 70% Mean PLA2R Antibody Reduction, Immunologic Remission In 5 Of 13 Patients At Week 12 In pMN Reported Saturday, Climb Bio Reports Initial PrisMN Phase 2 Data Showing 200 mg Budoprutug Delivered 70% Mean PLA2R Antibody Reduction, Immunologic Remission In 5 Of 13 Patients At Week 12 In pMN Benzinga 2026.10.26 06:42 (GMT+0) Open on Benzinga Other news Marjorie Taylor Greene Says FAA Ground Stop, US Tech-Related Outages Began After GOP Midterm Setback: 'Chaos Keeps Everyone Distracted' ‘Give Every American Family a $1700 Check’: Ro Khanna Says Compensate American Families for Iran War Picard Medical Q3 Sales $200.000K Miss $1.550M Estimate 'That's Up to President Xi': Trump Hints at Kim Jong Un Meeting in China, and Crypto Punters Are Hiking Odds Aggressively ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia Jensen Huang at SpaceX? Elon Musk Calls It an ‘Honor’ as Crypto Bettors Price in the Odds
Marjorie Taylor Greene Says FAA Ground Stop, US Tech-Related Outages Began After GOP Midterm Setback: 'Chaos Keeps Everyone Distracted'
'That's Up to President Xi': Trump Hints at Kim Jong Un Meeting in China, and Crypto Punters Are Hiking Odds Aggressively